MCL1 and breast cancer: Indeed, increasing evidence suggests that Mcl-1 is important in melanoma (Sale et al., 2019), hepatocellular carcinoma (Sieghart et al., 2006), breast cancer (Campbell et al., 2018), and various hematological malignancies (Wei et al., 2020).